false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Glomeru ...
APOL1-Mediated Kidney Disease: Update on Pathogene ...
APOL1-Mediated Kidney Disease: Update on Pathogenesis and Investigational Therapies
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Opeyemi Olibisi reviewed APOL1-mediated kidney disease, a recently recognized condition associated with G1 and G2 risk variants, most common among people with West African ancestry. Two risk variants substantially increase the likelihood and speed of kidney disease progression, though many carriers never develop disease. APOL1 contributes to several kidney injury patterns and can accelerate diabetic kidney disease.<br /><br />The proposed mechanism involves environmental or inflammatory “second hits” that activate APOL1 expression, particularly through JAK-STAT signaling. APOL1 may then disrupt kidney-cell function through its membrane-pore activity. This model is informing investigational treatments that inhibit JAK signaling, reduce APOL1 production, or block its pore function. Early trials report reductions in albuminuria, but whether these therapies preserve kidney function or prevent kidney failure remains unknown. Olibisi encouraged appropriate genetic testing, continued clinical evaluation—including biopsy when indicated—and referral of eligible patients to trials.<br /><br />In discussion, he explained that APOL1 variants protect against trypanosomes by enabling parasite destruction, while kidney-targeted treatment may ideally preserve circulating APOL1. The audience also raised evidence linking fetal APOL1 risk variants to low birth weight and impaired nephron development, suggesting a possible future role for postnatal screening and intervention.
Asset Caption
Opeyemi A. Olabisi, MD, PhD
Meta Tag
Speaker
Opeyemi A. Olabisi
Keywords
APOL1
kidney disease
G1 and G2 variants
West African ancestry
JAK-STAT signaling
albuminuria
genetic testing
×
Please select your language
1
English